CIK 0000914475
- Large accelerated filer
NEUROCRINE BIOSCIENCES INC
Sign in to watch- Ticker
- NBIX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330525145
- Phone
- +1 858-617-7600
- Business address
- 6027 EDGEWOOD BEND COURT, SAN DIEGO, CA, 92130
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,162,347
- in 4 filings, $3.2M under 10b5-1 plans
Net −$3,162,347. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-10-07 | Grigoriadis Dimitri E. Chief Research Officer | Option exercise | +5,000 | $43.24 | $216K | 87,273 |
| 2021-10-07 | Grigoriadis Dimitri E. Chief Research Officer | Sale | −5,000 | $104.85 | $524K | 82,273 |
| 2021-10-07 | Grigoriadis Dimitri E. Chief Research Officer | Option exercise · Non-Qualified Stock Option | −5,000 | $43.24 | $216K | 43,400 |
| 2021-10-04 | Cooke Julie Chief Human Resources Officer | Sale | −987 | $101.73 | $100K | 14,841 |
| 2021-08-16 | BENEVICH ERIC Chief Commercial Officer | Sale | −5,628 | $89.62 | $504K | 15,608 |
| 2021-07-27 | Lloyd-Smith Malcolm Chief Regulatory Officer | Sale | −16,709 | $93.80 | $1.6M | 15,801 |
| 2021-06-10 | LYONS GARY A Director | Sale | −10,000 | $100.27 | $1.0M | 213,697 |
| 2021-05-19 | Sharp Shalini Director | Grant or award · Non-Qualified Stock Option | +8,833 | 8,833 | ||
| 2021-05-19 | RASTETTER WILLIAM H Director | Grant or award · Non-Qualified Stock Option | +8,833 | 8,833 | ||
| 2021-05-19 | SHERWIN STEPHEN A Director | Grant or award · Non-Qualified Stock Option | +8,833 | 8,833 | ||
| 2021-05-19 | POPS RICHARD F Director | Grant or award · Non-Qualified Stock Option | +8,833 | 8,833 | ||
| 2021-05-19 | Norwalk Leslie V Director | Grant or award · Non-Qualified Stock Option | +8,833 | 8,833 | ||
| 2021-05-19 | MORROW GEORGE J Director | Grant or award · Non-Qualified Stock Option | +8,833 | 8,833 | ||
| 2021-05-19 | Mercier Johanna Director | Grant or award · Non-Qualified Stock Option | +8,833 | 8,833 | ||
| 2021-05-19 | LYONS GARY A Director | Grant or award · Non-Qualified Stock Option | +8,833 | 8,833 | ||
| 2021-04-15 | Mercier Johanna Director | Grant or award · Non-Qualified Stock Option | +17,180 | 17,180 | ||
| 2021-02-10 | Lloyd-Smith Malcolm Chief Regulatory Officer | Option exercise | +1,100 | $35.99 | $40K | 33,610 |
| 2021-02-10 | Lloyd-Smith Malcolm Chief Regulatory Officer | Sale | −1,100 | $119.96 | $132K | 32,510 |
| 2021-02-10 | Lloyd-Smith Malcolm Chief Regulatory Officer | Option exercise | +600 | $35.99 | $22K | 33,110 |
| 2021-02-10 | Lloyd-Smith Malcolm Chief Regulatory Officer | Sale | −600 | $119.95 | $72K | 32,510 |
Page 58 of 62 · 1,221 trades